Pakistani consul general in Jeddah marks National Day

H.E Mr. Khalid Majid, Consul General, Consulate General of Pakistan, Jeddah. (Supplied)
Short Url
Updated 23 March 2020

Pakistani consul general in Jeddah marks National Day

  • Message of H.E Mr. Khalid Majid, Consul General, Consulate General of Pakistan, Jeddah

23rd March marks the historic day when the Muslims of sub-continent decided to unite in their democratic demand for a separate homeland, where they could establish and practice their lives in accordance with Islamic values and traditions especially justice, equality, and freedom. Today, therefore, is an important occasion to pay tributes to the struggle and sacrifices of our founding fathers and pledge once more to live up to the ideals that form the foundation of the idea of Pakistan.

Pakistan and Saudi Arabia have deep rooted brotherly relations; encompassing a wide range of shared strategic, political, cultural and socio-economic objectives. Pakistan wishes to have a valuable partnership with Saudi Arabia, with the guidance and kind support of the Custodian of the Two Holy Mosques His Majesty King Salman bin Abdul Aziz Al Saud and Crown Prince HRH Muhammad bin Salman, for the realisation of shared developmental goals.

I would also like to acknowledge the valuable contribution of the vibrant and dynamic Pakistani community residing in the Kingdom. They are a strong link between the two brotherly countries and are serving both Pakistan and Saudi Arabia alike with loyalty, commitment and dedication.

Pakistan Consulate General has always strived to reinforce our community by providing them best possible services. The consular and welfare services have been made more efficient for quick redressal of issues.

I take this opportunity to convey my heartiest felicitations to the fellow Pakistanis residing in the Kingdom of Saudi Arabia and extend them my best wishes for their bright future.

Let us pledge to enhance our efforts to further deepen relations between Pakistan and Saudi Arabia, and also pray for the security and prosperity of both the brotherly nations.

Long Live Pakistan-Saudi Arabia Friendship!

  • Message of H.E Mr. Khalid Majid, Consul General, Consulate General of Pakistan, Jeddah


Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

Updated 27 May 2020

Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

  • Trials are being led locally as an essential means to verify the safety and effectiveness of a new drug
  • Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic

RIYADH: Clinical trials in Saudi Arabia could speed up the adoption of new drugs locally, a pharmaceutical executive has told Arab News.

“Clinical trials have two very big benefits for the Kingdom. Firstly, they provide data in the long run with respect to safety and efficacy, catered specifically to the Saudi population. Secondly, they impact local investment and build healthcare capabilities,” Managing Director of Eli Lilly Dimitri Livadas said..

Lividas further explained that the clinical trial phase of any new treatment is crucial as it represents the stage between the adoption or rejection of a drug. Working with the Ministry of Health and with a presence in the Kingdom for 42 years, the pharmaceutical company began research trials in the country in 2016, consisting of five pre-marketing activities and three monitoring studies for post-marketing.

Lividas added that the trials are being led locally as an essential means to verify the safety and effectiveness of a new drug before it is put to the market and introduced to patients. The majority of these are focused on diabetes, oncology, immunology, and osteoporosis.

“We genuinely believe that our future is here in Saudi Arabia. We continue to make great progress in having a commercial organization in the Kingdom that is fully staffed by Saudi nationals,” said Lividas.

As a biopharmaceutical company, Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic. It recently announced partnership with AbCellera to develop a treatment for the virus and aims to enter into clinical trials this year.

“I salute the Saudi authorities for their strong measures to contain the spread of COVID-19. I think it is an example to the world on how to do this. I would like to also express my gratitude toward all healthcare professionals who are currently on the frontlines, risking their own health to help others," Lividas said.